In this study, we show that DCs and MGCs in LCH lesions, as well as Mo-DCs from LCH patients, abnormally express BCL2A1/BFL1, a pro-survival member of the BCL2 family. The gene discussed is BCL2A1; the disease is Langerhans cell histiocytosis.